Armstrong Advisory Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Armstrong Advisory Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.4K	Hold	60	–	–	﹤0.01%	748
2026 Q2	$7.11K	Hold	60	–	–	﹤0.01%	752
2026 Q1	$6.23K	Hold	60	–	–	﹤0.01%	765
2025 Q4	$6.27K	Hold	60	–	–	﹤0.01%	750
2025 Q3	$5.55K	Hold	60	–	–	﹤0.01%	759
2025 Q2	$4.79K	Hold	60	–	–	﹤0.01%	752
2025 Q1	$4.96K	Hold	60	–	–	﹤0.01%	695
2024 Q4	$4.96K	Hold	60	–	–	﹤0.01%	695
2024 Q3	$5.22K	Hold	60	–	–	﹤0.01%	656
2024 Q2	$4.93K	Hold	60	–	–	﹤0.01%	653
2024 Q1	$4.57K	Hold	60	–	–	﹤0.01%	654
2023 Q4	$4.57K	Hold	60	–	–	﹤0.01%	654
2023 Q3	$4.34K	Hold	60	–	–	﹤0.01%	705
2023 Q2	$4.54K	Hold	60	–	–	﹤0.01%	675
2023 Q1	$4.56K	Hold	60	–	–	﹤0.01%	651
2022 Q4	$4.72K	Buy	+60	New	+$4.61K	﹤0.01%	668

Other funds holding PJP

Trilogy Capital Irvine, California $2.61B AUM 14.55% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return

Diversified Enterprises Wilmington, Delaware $2.16B AUM 14.54% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Armstrong Advisory Group's PJP Position: Q3 2026 in Review

Armstrong Advisory Group held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 60 shares worth $7.4K. The position accounts for ﹤0.01% of the portfolio, ranked #748.

Armstrong Advisory Group first reported a position in PJP in Q4 2022 and has held it in 16 quarters since. 21 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

Armstrong Advisory Group held 60 shares of Invesco Pharmaceuticals ETF worth $7.4K as of Q3 2026.
Armstrong Advisory Group left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #748 holding.
Armstrong Advisory Group first reported a position in Invesco Pharmaceuticals ETF in Q4 2022 and has held it in 16 quarters since.
21 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.